Company Filing History:
Years Active: 2019
Title: Innovations in Enzyme Variants by Nicholai Douglas
Introduction
Nicholai Douglas, an accomplished inventor based in Menlo Park, California, has made significant contributions to the field of biotechnology with his innovative work on enzyme variants. His research has opened up new avenues for applications in various industries, particularly in enzymatic processes.
Latest Patents
Nicholai Douglas holds a notable patent related to glycosyl hydrolase enzyme variants. This patent discloses variants of certain oxidoreductases from the glycosyl hydrolase family 61. The invention includes nucleic acids encoding these glycosyl hydrolase variants, compositions that comprise the variants, and methods for both producing and utilizing these enzymes. This patent reflects his dedication to advancing biotechnological solutions.
Career Highlights
Currently, Nicholai serves as a valuable member of Danisco US Inc., where he applies his expertise to further research and development in enzymatic innovations. His work has been integral in positioning the company at the forefront of enzyme technology. With a focus on creating efficient and effective enzyme variants, Nicholai continues to impact the industry positively.
Collaborations
Throughout his career, Nicholai Douglas has collaborated with talented coworkers, including Maria Foukaraki and Ronaldus Wilhelmus Hommes. Together, they have engaged in innovative projects that enhance the understanding and application of enzyme variants in various scientific and commercial fields. These collaborations highlight the importance of teamwork in driving research forward.
Conclusion
Nicholai Douglas is an inventor whose work with enzyme variants stands as a testament to the potential of innovation in biotechnology. His contributions through patenting unique glycosyl hydrolase enzyme variants not only benefit Danisco US Inc. but also pave the way for future advancements in the industry. As he continues to collaborate with other experts, the possibilities for new inventions remain limitless.